Ignite Creation Date:
2024-05-06 @ 6:43 PM
Last Modification Date:
2024-10-26 @ 2:53 PM
Study NCT ID:
NCT05759572
Status:
RECRUITING
Last Update Posted:
2024-02-06
First Post:
2023-02-26
Brief Title:
Apatinib With CDK46 Inhibitor and Endocrine Therapy in HR HER2- Advanced Breast Cancer
Sponsor:
Fudan University
Organization:
Fudan University
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-02-01
Start Date Type:
ACTUAL
Primary Completion Date:
2025-11-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2027-06-01
Completion Date Type:
ESTIMATED
First Submit Date:
2023-02-26
First Submit QC Date:
February 26 2023
Study First Post Date:
2023-03-08
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-02-04
Last Update Post Date:
2024-02-06
Last Update Post Date Type:
ACTUAL